Vodafone taps Boston for first m-health deal
This article was originally published in Clinica
Executive Summary
Telecommunications giant Vodafone has inked its first major deal in the m-health segment, signing up Boston Scientific to develop a monitoring system for patients with implanted cardiovascular devices. This includes implantable cardioverter defibrillators (ICDs) and cardiac resynchronisation therapy defibrillators (CRT-Ds).